# Chongqing Biocare Pharmaceutical Ltd. – FDA Inspection, Sep 22, 2023

Source: https://www.keypedia.com/records/fda_inspections/chongqing-biocare-pharmaceutical-ltd/bf1dc6a0-12a8-4a1e-8a3a-9a39bc6fc3f1
Source feed: FDA_Inspections

> FDA inspection 1219461 of Chongqing Biocare Pharmaceutical Ltd., September 22, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1219461
- Company Name: Chongqing Biocare Pharmaceutical Ltd.
- Inspection Date: 2023-09-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 970979 - 2016-04-28

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/djamila-harouaka/106cef03-a214-4184-963a-6580d3bd7fd9)

Company: https://www.keypedia.com/companies/chongqing-biocare-pharmaceutical-ltd/43b87a2f-392a-4858-ae70-9515bddeeadd

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c